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HSV-1 B capsids are composed of seven major proteins, designated VP5, VP19C, 21, 22a, VP23, VP24, and VP26. VP
indicates that the capsid protein is also a component of the infectious virion. Capsid proteins 21, 22a, and VP24 are specified
by a single open reading frame (UL26) that encodes 635 amino acids. An objective of the work in our laboratory is to
identify and map interactions among and between capsid proteins. In the present studies we employed the yeast GAL4
two-hybrid system developed by Fields and his colleagues (Nature 240, 245–246 (1989)) for this purpose. DNA corresponding
to the capsid open reading frames was derived as a PCR product and fused to sequences of the GAL4 activation and DNA
binding domains. Using this system each of the capsid proteins has been tested for interactions with all of the other capsid
proteins. Three interactions have been identified: a relatively strong self-interaction between 22a molecules (residues 307–
635 of UL26), bimolecular interactions between 22a and VP5, and another between VP19C and VP23. The interactions were
detected by the expression of b-galactosidase enzyme activity, and yielded 289, 86, and 63 units of enzyme activity,
respectively. For the 22a self-interaction, elimination of residues 611–635 resulted in an approximately twofold decrease
in enzyme activity. The C-terminal 25 amino acids of 22a were also essential for the bimolecular interaction between 22a
and VP5. q 1996 Academic Press, Inc.
Three types of capsids have been identified in herpes 22a (307–635) is translated in the same reading frame
from a second, shorter transcript (7, 12). For HSV-1 asimplex virus type 1 (HSV-1)-infected cells designated A,
B, and C corresponding to increasing distance sedi- second cleavage site between amino acids 610 and 611
of UL26 generates products referred to as the maturemented through sucrose gradients. B capsids contain a
centrally located (scaffold) protein that is replaced with forms of the proteins, as opposed to the full-length, or
precursor forms, representative of the primary translationviral DNA in the more rapidly sedimenting C capsids.
The slowest sedimenting A capsids are devoid of the products (8–10). 22a and to a lesser extent 21 occupy
scaffold protein and DNA, and may result from abortive the inner capsid space and act to form a scaffold upon
packaging events. The capsid shells of HSV-1 are com- which the icosahedral shell is constructed (1–3, 13). The
prised of four proteins, designated VP5, VP19C, VP23, human and simian-cytomegalovirus homologues of UL26
and VP26 (1 – 3). The major capsid protein, VP5, com- appear to have the same biological activities as those
prises the hexon and penton subunits of the icosahedral of HSV-1 and have been extensively characterized (see
capsid shell, VP19C and VP23 connect the subunits, and for example, 14–16). Gibson et al. (17) were the first to
VP26 is found on the tips of the hexons (4–6). The re- suggest that this protein may serve as a scaffold for
maining components of B capsids, 21, 22a, and VP24, capsid shell assembly in a manner analogous to bacte-
are encoded by a single open reading frame (ORF), UL26, riophage capsid assembly.
whose organization is depicted at the top of Fig. 1. The The proteins of the UL26 ORF may be thought of as
UL26 gene product encodes an autocatalytic protease maturational as well as structural capsid proteins, as
(7, 8) which cleaves the UL26 gene product between opposed to the four proteins that comprise the capsid
residues 247 and 248 to generate VP24 (1–247) and 21 shell that seem to have only a structural role in assembly.
(248–635) (9 – 11). The more abundant capsid protein, There are probably a number of other viral-specified pro-
teins with roles in capsid maturation that may be present
in capsids in low copy numbers and may not be compo-
1 To whom correspondence and reprint requests should be ad- nents of completed virions. By analogy to bacteriophage
dressed at current address: Virology Laboratories, Department of Phar-
assembly these include DNA packaging and associatedmacology and Molecular Sciences, Johns Hopkins University School
docking proteins, proteins that bend DNA and proteinsof Medicine, 725 N. Wolfe Street, Baltimore, MD 21205. Fax: (410) 955-
3023. that plug the hole used for DNA packaging. Recently the
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FIG. 1. Characterization of capsid protein interactions. The UL26 ORF is shown at the top of A. The position of the autoproteolytic cleavages are
indicated between residues 247 and 248 and between 610 and 611. Cleavage after residue 247 generates VP24 and 21 from the UL26 translation
product. 22a is translated from a second transcript whose initiation codon is at position 307 of the UL26 ORF. The protein coding regions are
shown as horizontal lines and relevant terminal amino acid residues are marked at the ends of the lines. Replacement cloning and complete
nucleotide sequence analysis were not performed for the 22a mutant constructs, although the termini were shown to be correct by DNA sequencing.
In B, the VP5 coding region was cloned into pGBT9 and 22a into pGAD424. In C, VP19C was cloned in pGBT9 and VP23 in pGAD424. DNA
amplification and cloning was as indicated in the legend to Table 1. The transformation of Y526 and subsequent measurement of enzyme activity
were also as described in the legend to Table 1. Enzyme units { one standard deviation are shown at the left of each construct and are the
averages of three determinations.
UL6 gene product was shown to be a capsid protein and requires that both domains be in close proximity in order
to interact with the basal transcriptional complex. Nor-may be representative of one of these proteins (18).
The purpose of the present experiments was to detect mally the two domains are joined by covalent bonds but
Fields and his colleagues showed that weak interactionsmolecular interactions among the capsid proteins of
HSV-1 using the yeast two-hybrid system (19–21), which between proteins fused to each domain also resulted in
transcription. Transcriptional activation was measuredemploys the yeast transcriptional activator, GAL4, char-
acterized by Ptashne and his colleagues (see for exam- using a lacZ reporter gene fused to a GAL4 responsive
promoter (GAL1). Two plasmids were employed; one,ple, 22–24 ). The GAL4 protein consists of a DNA binding
domain (residues 1–147) and a transcriptional activation pGBT9, encodes the DNA binding domain and the other,
pGAD424, specifies the GAL4 activation domain. Poly-domain (residues 768–881), which are distinct and sepa-
rable (22). Transcriptional activation of a gene by GAL4 linkers in these plasmids allow the insertion of test pro-
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tein sequences in phase with, and downstream from, the ture (307–610), form of 22a was employed. The interac-
respective GAL4 domains. pGBT9 also encodes the TRP1 tion between VP5 and 22a (and UL26) was only obtained
gene and pGAD424 encodes the LEU2 gene so that fol- when VP5 was expressed from pGBT9.
lowing transformation of appropriate yeast cells, colonies A second yeast cell, HF7c (26), was employed to deter-
may be selected that grow in the absence of leucine and mine if the same interactions would be detected when
tryptophan. Colonies can be assayed directly for enzyme the b-galactosidase reporter gene was fused to a differ-
activity by the appearance of blue color using X-GAL as ent promoter. The lacZ gene in HF7c is fused to the TATA
a substrate (19). portion of the CYC1 promoter into which three copies
Sequences encoding each capsid protein of HSV-1 of a GAL4 responsive (17-mer) DNA binding site were
were obtained as PCR products and cloned into both inserted. Leucine- and tryptophan-independent trans-
plasmids. Constructs representing the entire UL26 ORF formants were obtained as described above and assayed
(residues 1–635), and 22a (residues 307–635), were for enzyme activity using X-GAL screening. The three
used in this assay. Wherever possible the capsid pro- capsid protein interactions detected using Y526 were
teins were tested when present in both vectors. Most also detected using the GAL4 responsive CYC1 promoter
experiments utilized Y526 yeast cells. The Y526 cell con- in HF7c. In addition, the upstream activating and TATA
tains the lacZ reporter sequence fused to the upstream sequences of the GAL1 promoter are fused to the HIS3
activating and TATA sequences of the GAL1 promoter gene in HF7c, so that growth in the absence of histidine
(19). Following transformation, colonies that developed requires GAL4-dependent transcription. Transformed
on plates containing selective growth media were as- cells were prepared as described above and aliquots
sayed for the development of blue color. The results are were spread onto the surface of selection plates that
summarized in Table 1. A total of three interactions, des- did not contain histidine. Colonies were formed when
ignated by a /, were detected; a bimolecular interaction plasmids were used that gave rise to the three capsid
between VP5 and 22a (and with UL26), another between protein interactions observed by X-GAL screening. All
VP23 and VP19C, and a self-interaction between 22a of the colonies formed gave a positive response in the
molecules. Blue color, in all of the colonies, was detect- presence of X-GAL and at times that were similar to those
able after 20 min of incubation for the 22a self-interaction for the leucine- and tryptophan-independent colonies. No
and after approximately 40 min for the other interactions. additional interactions were detected using HF7c cells.
No interactions were detected for VP24 and VP26, either In summary the same capsid protein interactions found
with themselves or with the other capsid proteins.
with Y526 were also detected with HF7c using a genetic-
The enzyme units of b-galactosidase expressed as
screen assay and a phenotypic-selection assay for col-
nanomoles of ONPG hydrolyzed per minute per milligram
ony formation.
of total protein were determined for each interaction and
Additional constructs were prepared and tested in or-are listed in the shaded squares of the Table. An interac-
der to localize portions of the capsid proteins responsibletion between cellular p53 and SV40 T-antigen produced
for the molecular interactions. Results are shown in Fig.approximately 150 units of enzyme activity when em-
1. Mapping experiments for the self-interaction of 22aployed in the two-hybrid system (25), a value that we
are shown in Fig. 1A. The C-terminal residue for eachalso obtained when these constructs were used as a
construct is indicated to the right of that construct andpositive control. The self interaction between 22a scaf-
the N-terminal residue to the left, when the number isfold molecules resulted in a similar level of enzyme activ-
different from that of the authentic start position (residueity (289 units). The two vectors without inserts resulted
307 of UL26). The self-interaction of the precursor form ofin 0.4 { 0.3 units of activity (standard deviations are not
22a gave the highest value for b-galactosidase enzymelisted in Table 1 but are given in Fig. 1). Therefore, values
activity (289 enzyme units). By contrast, 138 units weregreater than this value, or approximately 1 unit of enzyme
obtained when the mature form of 22a (22a-610) wasactivity, represent a positive response, as was noted by
used in the two vectors. Shortening of the C-terminus ofLi and Fields (25). VP19C and 22a inserted into the DNA
22a-610 to residue 504 reduced the activity to 88 units,binding domain of pGBT9 each produced a false positive
while a further shortening to residue 457 resulted in anresponse (enzyme activity in the presence or absence of
almost complete loss of b-galactosidase activity (1.6an activation domain) of 3 and 8 units of activity, respec-
units). Similar enzyme activities were obtained when thetively (Table 1, column 2). Interactions given in the Table
C-terminal mutant constructs were tested against the full-that employ these constructs have not been corrected
length molecule. A polypeptide that terminated transla-for the small false positive activity. The signal of the
tion at amino acid 418 abolished enzyme activity com-false positive response of 22a and VP19C, as judged by
pletely, as did deletion of N-terminal residues up to 375enzyme activity, did not increase in the presence of an-
in the 22a-504 construct. We conclude that the N-terminalother noninteracting capsid protein in pGAD424. The
residues up to approximately amino acid 504 are essen-false positive interaction noted above for pGBT9-22a was
detected when the precursor (307–635), but not the ma- tial for the 22a self-interaction and that the 25 C-terminal
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TABLE 1
HSV-1 Capsid Protein Interactions
Note. Plasmids encoding each of the capsid proteins were used in standard PCR reactions. These were: for VP23 (UL18), pKKI; for VP5 (UL19),
pKBgN (37 ); for the UL26-specified proteins, pKNotI (1); for VP26 (UL35), pKEL; and for VP19C (UL38), a 3.8-kb BamHI/Sal I fragment derived from
pKBH (unpublished). Oligonucleotide primers were used that annealed to DNA encoding the first and last six amino acids for the coding and
noncoding strand, respectively. The 5*-end of the coding strand primer terminated with an EcoRI site, and the 5*-end of the noncoding strand primer
terminated in a BamHI site for UL18, UL35, and UL38, and a Bgl II site for UL19 and UL26. Agarose gel-purified fragments were cloned into the
EcoRI/BamHI sites of pGBT9 and pGAD424 (19) (Obtained from Dr. S. Fields). For VP5, VP19C, VP23, 22a, 22a-610, and UL26 most of the DNA
obtained by PCR was replaced with authentic sequences derived from the clones noted above that had previously been shown to express functional
proteins. The remaining 5* and 3* terminal regions of each gene were sequenced and found to be the same as the corresponding sequences
reported by McGeoch et al. (38) for HSV-1 strain 17. DNAs were prepared using Qiagen kits (Chatsworth, CA). The yeast cell, Y526 (also obtained
from Dr. S. Fields) was grown in YEPD medium, and competent cells were prepared and transformed for leucine and tryptophan essentially as
described by Bartel et al. (19). Early log phase cells were pelleted, washed with water, and resuspended in 1/30 original volume in TE (10 mM Tris,
pH  7.5, 1 mM EDTA) containing 100 mM lithium acetate (pH  7.5). Each transformation reaction contained 100 ml of cells, 20 mg salmon sperm
carrier DNA, and 0.35 mg of each plasmid. The reactions were incubated at room temperature for 30 min (inverted approximately every 5 min), prior
to the addition of dimethylsulfoxide (70 ml) and exposure to a heat shock (427 for 15 min). Cells were pelleted and resuspended in 200 ml TE and
125 ml was spread directly onto wetted Whatman No. 1 filter papers placed on the surfaces of selection plates composed of SD media lacking
leucine, trytophan, and uracil. Cells were incubated for 3 days at 307 and approximately 300 colonies grew on the filters. Filters were lifted from
the plate and assayed for the appearance of blue color using X-GAL as a substrate for b-galactosidase (filter assay). Subsequently, b-galactosidase
enzyme activity was measured using o-nitrophenyl-b-D-galactopyranoside (ONPG) as substrate (liquid culture assay). For the latter 5 ml of SD media
without leucine, tryptophan and uracil were added to the culture dishes containing transformants and the yeast cells in the colonies were scraped
into the media. Assays were generally done directly on the resulting cell suspension. Aliquots of the crude lysate were assayed for b-galactosidase
activity as described by Rose et al. (39). However, the protein concentration was determined by the Lowry (40) rather than the Bradford method.
The development of color produced by the metabolism of ONPG was measured as absorbance units at 420 nm and protein determinations were
at 750 nm, following sedimentation for 3 min in a microfuge to remove debris. The units of enzyme activity are nanomoles of ONPG cleaved per
minute per milligram of protein, and the absorbance of 1 nm of ONPG at 420 nm was taken as 0.0045 (41). Pairs of capsid proteins that resulted
in interactions are indicated by shaded squares, and the number of units of enzyme activity are given within the shaded squares. Results indicated
by w gave enzyme activities that were not significantly greater than the false positive values produced by pGBT9-19C or pGBT9-22a.
amino acids increase the interaction by approximately tuted for 22a and 22a-610, respectively. However, for the
pGBT9-VP5/pGAD424-UL26 combination 20 units of b-twofold.
The C-terminal 25 residues of 22a were also essential galactosidase activity were obtained.
This is the first report of a self-interaction between 22afor its interaction with VP5. When the precursor form of
22a was expressed from pGAD424 and VP5 from pGBT9, scaffold molecules. The relative strength of the interac-
tion is similar to that reported previously for p53 and86 units of enzyme activity were observed (Fig. 1B). How-
ever, using the mature form of 22a (22a-610) the back- the SV40 T-antigen. This relatively strong interaction was
somewhat of a surprise because monomer formation isground level of enzyme activity was detected. The same
result was obtained if UL26 and UL26-610 were substi- likely required for scaffold exit from fully formed B-cap-
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sids. Monomers of 22a have a similar mass to the phage thirds portions of each molecule were negative when
tested with a full-length copy of the other member of theP22 scaffold protein which has an axial ratio of 9:1 (27 ).
For the same axial ratio, the monomer diameter of 22a interacting pair. This may mean that lacZ expression is
due to interaction of noncontiguous portions of each mol-would be approximately 20 A which is small enough to
exit the 40 A penton pores in the capsid (6). The cleavage ecule, and mapping the interactions will require an ap-
proach that reflects their 3D nature.of the scaffold protein for HSV-1 may serve to terminate
the scaffold/major capsid protein interaction and to pro- Using nonreducing and reducing two-dimensional gel
analysis of proteins prepared from HSV-2 capsids, Zweigmote subsequent monomer formation. The increase in
the 22a self-interaction, due to the presence of the C- et al. (36) demonstrated the existence of disulfide cross-
links between the VP5 and VP19C counterparts of HSV-terminal 25 residues, may promote oligomerization of
scaffold molecules and help to minimize protease cleav- 2. Chemical cross-linking experiments were reported re-
cently for HSV-1 B capsids (1). Cross-links were detectedage until the interaction with VP5 occurs. If the C-terminal
residues are essential for scaffold formation, then the between VP5, VP19C, and VP23 and another between
VP5, VP19C, and 22a. It is somewhat surprising that thescaffold-like structures observed using constructs that
express precursor and mature forms of 22a in insect yeast two-hybrid system did not detect an interaction
between VP5 and VP19C. However, as is often the casecells may not be representative of viral-infected mamma-
lian cells (28, 29). the two-hybrid system detects most, but not all, of the
interactions indicated by a variety of other techniques.The data presented here for the VP5-22a interaction
are consistent with those from other experiments. Amino The future goal of our work is to use the two-hybrid
system to identify and characterize the domains involvedacid residues 611–635 of HSV-1 22a have been shown
to be required for capsid formation in HSV-1-infected in the interactions reported here, and to use other tech-
niques to uncover additional capsid protein interactions.Vero cells (30) and insect cells infected with recombinant
baculoviruses (28, 31). Hong et al. (32) showed that as
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